Technological and Patent Evolution of Murine Monoclonal Antibodies
Journal Title: Journal of Advances in Biology & Biotechnology - Year 2017, Vol 14, Issue 2
Abstract
Among the pharmaceutical products targeted for patent protection, monoclonal antibodies stand out. Technological advances involving monoclonal antibodies aim to minimize detrimental human immune responses to antibodies (e.g., human anti-murine antibodies [HAMA]) and increase the binding affinity of antibodies to their antigen, making them more specific for their therapeutic target. This work evaluates the main technological advances pertaining to monoclonal antibodies, from the creation of technology for the immortalization of cells to generate hybridomas through the generation of chimeric and humanized antibodies by genetic engineering techniques, phage display technology, and transgenic mice. It also aims to provide an overview of commercially available and patented murine monoclonal antibodies and to correlate the main players, markets, and therapeutic uses for which the antibodies were developed. The study of mMAB (murine monoclonal antibodies) proved to be of great importance to understand how the development of these antibodies and their protection by patents affects their therapeutic use in cancer patients, in diagnostics, to treat inflammation, etc. The United States (US), Japan (JP), France (FR), and China (CN) constitute potential markets for these protected technological advances. Among current usage trends of three murine monoclonal antibodies whose patents have expired, the use of generic and/or biosimilar is evidenced, as well as the use of these assets to guarantee the protection of new products, new associated processes (e.g., new combinations, associations, or dosage forms), or new processes. The newest market trends related to patent protection in this technological area incorporate the use of monoclonal antibody fragments.
Authors and Affiliations
Kátia dos Reis, José Procópio Moreno Senna, Nei Pereira Júnior, Maria Antonieta Peixoto Gimenes Couto
Keywords
Related Articles
- EP ID EP318148
- DOI 10.9734/JABB/2017/34759
- Views 103
- Downloads 0
Association of Transcription Factor 7 Like 2 (TCF7L2) rs12255372 (G/T) Gene Polymorphism and Type 2 Diabetes Mellitus
Aim: The rs12255372 of transcription factor 7 like 2 (TCF7L2) was found to be associated with risk of type 2 diabetes mellitus (T2DM) in different populations worldwide. Therefore in the present study we study the relati...
Nutritional and Molecular Analysis of Wild Edible Gelam Mushroom (Boletus sp.) from Kelantan, Malaysia
Aims: To conduct nutritional and molecular analysis of Gelam mushroom which is believed to have contained medicinal properties. Place and Duration of Study: School of Biosciences and Biotechnology, Faculty of Science and...
Synthesis and Characterization of Polymeric Nanoparticles Formed from Cowry Shells and Acacia Gum Extracts
The study investigated the morphology, dimension, and composition of polymeric nanomaterials obtained from cowry shells and Acacia tree gum arabic extracts. Chitosan and gum arabic were extracted from cowry shells and Ac...
Comparative Assessment of Pleurotus sajor-caju (Oyster Mushroom) Yield Cultivated from Indigenous and Exotic Wood Wastes
The study assessed the yield of Pleurotus sajor-caju cultivated from the sawdust of four wood species: Triplochiton scleroxylon and Ceiba petandra (indigenous tree species), Gmelina arborea and Tectona grandis (exotic tr...
Correlating Zinc Phytoaccumulation of Cyperus iria Linn with Soil Chemical Parameters in a Metal Contaminated Soil Amended with Orange Peels
Correlating Zinc phytoaccumulation of Cyperus iria Linn with Soil chemical parameters in a metal contaminated soil amended with orange peels (waste) was investigated at the Center for Ecological Studies, University of Po...